U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C22H36O5
Molecular Weight 380.5182
Optical Activity ( + / - )
Defined Stereocenters 5 / 5
E/Z Centers 3
Charge 0

SHOW SMILES / InChI
Structure of PROSTALENE

SMILES

CCCCC[C@@](C)(O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC=C=CCCC(=O)OC

InChI

InChIKey=GNIYHUSSKSFYBD-MFZPGRHISA-N
InChI=1S/C22H36O5/c1-4-5-10-14-22(2,26)15-13-18-17(19(23)16-20(18)24)11-8-6-7-9-12-21(25)27-3/h7-8,13,15,17-20,23-24,26H,4-5,9-12,14,16H2,1-3H3/b15-13+/t6?,17-,18-,19+,20-,22-/m1/s1

HIDE SMILES / InChI

Description

Prostalene is an analogue of prostaglandin PGF-2 alpha. It is used for the control of estrus in mares.

Originator

Syntex
47

Approval Year

Unknown
139,594

Targets

Primary TargetPharmacologyConditionPotency
prostaglandin F receptor (FP)
1
Agonist
2,678

Conditions

ConditionModalityTargetsHighest PhaseProduct
Pregnancy
65
 Preventing
Approved
8,429
Synchrocept B

PubMed

Patents

US20090252685
1
US5369128
1
WO2005107702A2
1

Sample Use Guides

In Vivo Use Guide
Conditions of use in horses --(1) Amount. Administer 5 micrograms per kilogram of body weight as a single subcutaneous injection.
Route of Administration: Other
In Vitro Use Guide
Unknown
ACTIVE MOIETY
Structure of PROSTALENE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966